Myeloproliferative neoplasms: open trials in Taiwan

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Taoyuan

  Registry updated 2026-11-09

• NCT07357727

  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Changhua · Kaohsiung City · Tainan · Taipei

  Registry updated 2026-11-06

• NCT07623161

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  Trial Treatment · Phase 3 · Takeda

  Kaohsiung Medical University Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei

  Registry updated 2026-11-06

• NCT04064060

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Trial Treatment · Phase 3 · Celgene

  Kaohsiung, San Ming Dist. · Taichung · Taipei

  Registry updated 2026-07-01

• NCT05980806

  A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

  Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc

  Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · National Taiwan University Hospital, Taipei · Taoyuan Chang Gung Memorial Hospital, Taoyuan

  Registry updated 2026-02-12

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error